Tag: AGEN

Blue Horseshoe Stocks: APP, CERS Recaps & More

American Apparel Inc. APP

It appears as if we brought APP back into the discussion yesterday at an opportune time, as the stock enjoyed a healthy intraday move on more than twice the 3-month average trading volume.

After briefly seeing a low of .63 the stock gradually built its way up to an afternoon high of .69, an increase of roughly 10%, and in the premarket this morning APP has already traded as high as .78. That pushes the overnight increase on APP to 24%

Yesterday we mentioned that breaking of the 200DMA of .74 was a key event that needed to take place and we’ve seen that happen this morning, so APP is certainly going to remain high on our watchlists as we head into week’s end.

Cerus Corp. CERS

CERS was included in yesterday’s extended watchlist, and made a solid move during the day’s session. From a low of 5.26 the stock made a run at a high of 5.94, a modest yet notable 13% increase.

It came on the heels of the announcement that the company had received the green light from the FDA on its product that limits the risk of infection-transmission in blood transfusions. We always like a good FDA-approval play so we will definitely be monitoring this play in coming sessions.

CONCORD, Calif.–(BUSINESS WIRE)–Cerus Corporation (CERS) today announced that the U.S. Food and Drug Administration (FDA) has approved the INTERCEPT Blood System for plasma. The INTERCEPT plasma system is approved for ex vivo preparation of plasma in order to reduce the risk of transfusion-transmitted infection (TTI) when treating patients requiring therapeutic plasma transfusion. >> FULL PR

Eco Science Solutions, Inc. ESSI

We’ve still got ESSI on our radars, and wanted to remind our readers of this even as the stock has been trading in a tight channel between .20-.25 since we last took a look at it. The reason we still find ESSI attractive is that it boasts a tight share structure, and while we haven’t seen much in the way of volume, should that change, even the slightest amount of buying pressure could send ESSI flying.

From a business perspective, we’re also interested in the technology the company is working on, its innovative re-imagining on classic spark plug design. So despite not seeing much short-term activity, ESSI still has many of the hallmarks of a high-potential play that we’ll want to watch closely into the New Year.

We’ve drawn up a video on the current standing of the ESSI Chart, so take a look at that by clicking the graphic below:

If you missed our initial report on ESSI and its spark plug technology, go ahead and take a look now: ESSI Report

Extended Watchlist:
RAD, JNUG, EXXI, FRO, RGSE, AGEN, NQ, THCZ

Blue Horseshoe Stocks: NSCT Exclusive CEO Interview

Cloud Medical Doctor Software Corp. NSCT

We’ll start things off this morning by turning our attention back to NSCT; we brought it into the fold for the first time this week as a longer-term play. The chart appeared to have to some ripening to do, as it searched for a bottom and yesterday’s session appears to have brought one. The came down to bounce off of the .0522-mark, and subsequently closed at its high-of-day .0648, a 24% intraday move.

In addition to seeing some early success on the NSCT chart this week, we had the honor of conducting an exclusive interview with the company’s CEO, Mr. Michael DeLaGarza via our sister site, Stock Traders Talk. It covers quite a bit, so we suggest you visit the site, or click the following graphic to bring up the interview straight away: 

HENDERSON, Nev., July 24, 2014 (GLOBE NEWSWIRE) — via PRWEB – The interview will be held on July 24, 2014 at 9:00 am EDT, An archived recorded version can be found on the homepage of Stock Traders Talk at http://www.stocktraderstalk.com, following the interview.

This interview will discuss Cloud-MD’s Software, services and our CipherShop Division which provides commercial quality, advanced, digital security solutions that comply with governmental regulatory requirements, such as HIPAA and SOX and their CipherLoc product suite offers both an advanced Polymorphic Cipher Engine and a Polymorphic Hardware Engine.

Intuitive Surgical, Inc. ISRG

Our call of ISRG yesterday morning couldn’t have been much better, with the stock putting forth a heck of a performance in the ensuing session. It traded in a range from 438.55 – 463.39 on the day, and as a result, anyone who was entertaining options calls as we pointed out had the chance to make substantial gains.

The landmark session came on the heels of two morning PR’s that you may want to click through to, below:

Facebook, Inc. FB Options

Another great call of ours this week was the FB Calls that we brought to the table first thing Monday morning, stating: “We’ll be looking to capitalize on the volatility that comes with rising anticipation of earnings, due for release on Wednesday.”, and noting that we’ve used this scenario to our advantage in the past.

Wednesday came and went, earnings exceeded expectations, and our FB Calls offered up big gains just as we surmised. The stock traded in a daily range from 69.61 – 71.33, and this morning in premarket trading, has reached as high as 78.44.

To adjust our strategy on FB options, we’ll be monitoring the $75-77 Calls as we head into week’s end.

Extended Watchlist:
ARIA, ONCO, CLSN, AGEN, JDST

Blue Horseshoe Stocks: FB, TWTR, POWR, ONVO & More

Facebook, Inc.  FB
& Twitter, Inc. TWTR

After we included FB and TWTR in our extended watchlist yesterday, the two social media giants both made positive moves on the day. The uptrends made trading in the options chains of each of these plays a lucrative venture for the session.

For example, looking at some of the options contracts that were relatively close to the money, FB $66 calls went from .48-1.64, and $67 Calls were as low as .21 and closed at .86. TWTR $39 Calls were also moving, trading in a range from  .24 to .90. No matter what big-board stock you’re looking at options in, the heaviest action will usually be close to the money (i.e. Current market price as it relates to the “strike-price” of a given contract)

PowerSecure International, Inc. POWR

POWR was a feature in yesterday’s report, wherein we tagged the stock for its potential to fill in a huge gap on its chart that goes all the way to the $18-range. We began to see the gap beginning to fill as POWR would make a modest intraday run to a high of 9.79.

We’re going to leave this play on our watchlist as we head into the week’s end and beyond, as it still has much ground to recover. A return to pre-gap levels on the chart would still equate to gains in excess of 100% from here, and there isn’t a whole lot in the way of obvious resistance until we hit the 50DMA (12.27).

On the options side of things, we’re particularly interested in the August $10 Calls (Closed at .75 yesterday), because if POWR can test that 50DMA by 08/16, we could be looking at triple-bag gains from those contracts.

Organovo Holdings, Inc. ONVO

We placed ONVO on watch in Tuesday’s report, as we noticed that unlike some of the other players in the 3D printing industry, it had yet to show a significant uptrend on the chart, and we thought it might be due to make a move.

It appears that alert was quite timely, as the stock is beginning to rear its head,  gapping up today to the tune of 13% in premarket trading. Key resistance at the 200DMA (8.07) has been broken, and if we can hold above that mark, the next areas of resistance crop up at 8.65, and 9.35.

Comments on Today’s GoPro IPO

A large portion of the buzz on the Street today is emanating from the highly-anticipated GoPro Initial Price Offering, and we’re going to take the same stance we always take in these situations.

Our M/O when a big IPO comes out has always been to wait in the wings until we can gauge the price action. Once we get a good feel for the nature of the beast, it’s then that we’ll step in and utilize the trends to our best advantage in the options chain. This strategy served us well on both the FB and TWTR IPO’s, so we’ll continue to use it here.

Extended Watchlist:
AA, ROYL, DRWI, AGEN, UNXL

REVI Follow-Up Report & Extended Watchist

Resource Ventures, Inc. REVI

We’re revisiting REVI this morning, a printing and graphics stock that has recently brought us the chance at some very impressive gains. Many of you will recall our initial REVI report, which we published back on January 21st.  That day, the stock would afford us the opportunity at a 42% intraday gain as it ran from a low of .0074 to .0105.

On January 28th we conducted, via our sister site StockTradersTalk.com, an exclusive interview with REVI CEO Michael Cipolla. It provided some unique insight; we learned a lot about Michael and the company, and would highly suggest anyone that missed the interview to check it out now. GO TO INTERVIEW>>

We touched base with REVI once again on February 5th, when a PR informed us of the company’s intent to branch into the industrial hemp industry in order to take advantage of the recent boom in interest for cannabis related stocks. REVI signed a consulting agreement with a subsidiary of well-known Hemp, Inc. (HEMP). We passed this along to our readers that morning, and anyone who happened to be paying attention was handsomely rewarded. The stock shot up from a daily low of .015 to as high as .056, a 273% intraday spike.

Further along into this month, we learned that REVI’s consulting agreement with HEMP led to a joint venture. The two have collaborated to conceptualize “The Hemp Nation Magazine”, a magazine that will have its content produced by Hemp, Inc. with printing and publishing duties falling to REVI. You can catch a preview of the website at  www.hempnationmagazine.com to be launched with full functionality coming up on the 4th of July. In addition to the online portion of the magazine, a subscription-based initial run of 100,000 copies is slated to be printed by Resource Printing (REVI)  Read PR>>>

On February 18th, REVI published its earnings report, which reflected record annual revenues of $2,311,959, as well as record net income of $166,559 for 2013. The news sparked another run when trading resumed on the 19th, and REVI reached a new high of .0765. From our initial alert low of .0074, that’s a monstrous positive move of 934% covered in just under a month’s time.

Perhaps the most exciting part, is that the record setting earnings came on the strength of REVI’s core business. When one takes into account the added venture of The Hemp Nation Magazine, REVI’s new-found direction, it is imperative that we keep this stock on our radars moving forward and follow this storyline through to its conclusion.

We prepared a video of the REVI Chart for your convenience:

This morning, REVI released an update PR which included not only some of the things that we’ve just outlined, but mentions one of the company’s other projects, WikiClickPrint. According to the release, development of the WikiClickPrint On-line Printing Platform is ongoing, “The full rollout of Wikiclickprint is very close and our customers will love it” said Kaiser.

RECENT PRESS AND OTHER RELEVANT LINKS:

The Hemp Nation Magazine

Hemp, Inc. Website

Resource Printing Website

WikiClickPrint Website

REVI 2013 Annual Report

Extended Watchlist:
RFMD, TQNT, WAVX, ANAD, MSTX, AGEN, PTN

BLRX, LSI, FREE & Extended Watchlist

BioLineRx, Ltd. BLRX

BLRX popped our scanner this morning, and we thought we’d pass it along as it appears to be one of this morning’s most active in pre-market trading. The stock is gapping up on the heels of an early-morning press release.

It has been filling a large gap on the chart for the past several months, and we wanted to radar the stock this morning as a total fill back to levels observed this past Spring could mean significant gains from current levels.

JERUSALEM, Dec. 16, 2013 /PRNewswire via COMTEX/ — BioLineRx (NASDAQ: BLRX; TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML). >>>Read Full PR

LSI Corp. LSI

Another stock to turn up on our morning scan is LSI. We are witnessing a heavy gap-up as the stock is currently trading up roughly 40% in pre-market trading.

At current levels in the 11.00-range, LSI qualifies for Bluesky Breakout status, so this is definitely one we want to monitor as we begin this new trading week.

FreeSeas, Inc. FREE

We are re-alerting FREE this morning. Some of you may recall back in September, when we rode this play from less than a dollar, all the way up to mid-4.00 range. The stock has generally consolidated since that time, and is now coming off of its bottom.

Chart indicators point to potentially large gains in the near future, with the MACD having just undergone a bullish cross, and the RSI sharply rising, preparing challenge the 50-line.

After yielding us gains of more than 400% the first time, we are eager to see what the current trend could produce.

Extended Watchlist:
INOL(trading at all time lows), S, BRD, AGEN, SLTM, PATH, WYY, RVLT, HNR

Get Our FREE Daily Reports!

SUBSCRIBE